BCR-ABL(T315I) transcript disappearance in an imatinib-resistant CML patient treated with homoharringtonine: a new therapeutic challenge? (Q80413372)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17541396%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

title

BCR-ABL(T315I) transcript disappearance in an imatinib-resistant CML patient treated with homoharringtonine: a new therapeutic challenge? (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17541396%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

author name string

Legros L

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17541396%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

Hayette S

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17541396%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

Nicolini FE

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17541396%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

Raynaud S

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17541396%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

Chabane K

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17541396%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

Magaud JP

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17541396%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

Cassuto JP

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17541396%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

Michallet M

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17541396%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

publication date

31 May 2007

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17541396%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17541396%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

volume

21

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17541396%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

issue

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17541396%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

page(s)

2204-2206

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17541396%20AND%20SRC:MED&resulttype=core&format=json

Monitoring CML patients responding to treatment with tyrosine kinase inhibitors: review and recommendations for harmonizing current methodology for detecting BCR-ABL transcripts and kinase domain mutations and for expressing results

31 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404772

7 January 2021

Overriding imatinib resistance with a novel ABL kinase inhibitor

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404772

7 January 2021

Mutation status and clinical outcome of 89 imatinib mesylate-resistant chronic myelogenous leukemia patients: a retrospective analysis from the French intergroup of CML (Fi(phi)-LMC GROUP)

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404772

7 January 2021

Clinical outcome of 27 imatinib mesylate-resistant chronic myelogenous leukemia patients harboring a T315I BCR-ABL mutation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404772

7 January 2021

MK-0457, a novel kinase inhibitor, is active in patients with chronic myeloid leukemia or acute lymphocytic leukemia with the T315I BCR-ABL mutation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404772

7 January 2021

Standardization and quality control studies of 'real-time' quantitative reverse transcriptase polymerase chain reaction of fusion gene transcripts for residual disease detection in leukemia - a Europe Against Cancer program.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404772

7 January 2021

Identifiers

DOI

10.1038/SJ.LEU.2404772

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17541396%20AND%20SRC:MED&resulttype=core&format=json

Dimensions Publication ID

31 December 2019

1036102109

0 references

1 reference